RXST DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages RxSight, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – RXST

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of RxSight, Inc. during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - The Class Period for the lawsuit is from November 7, 2024, to July 8, 2025, inclusive [1]. - Investors who purchased RxSight securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by September 22, 2025 [2]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time [3]. - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013 [3]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for its clients [3]. Group 3: Case Allegations - The lawsuit alleges that RxSight made false and misleading statements regarding its business, including claims of "adoption challenges" and overstated demand for its products [4]. - It is claimed that these misrepresentations led to RxSight being unlikely to meet its previously issued financial guidance for fiscal year 2025 [4]. - The lawsuit asserts that when the true details about RxSight's performance became known, investors suffered damages [4].